...
机译:与癌症AF患者中的华法林相比,新口腔抗凝血剂的安全性和疗效:随机临床试验和观察研究的荟萃分析
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Iron &
Steel Grp Dept Cardiol Gen Hosp Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Cardiol Chongqing Peoples R China;
Atrial fibrillation; Cancer; Anticoagulant; Meta-analysis;
机译:非毒素K拮抗剂口腔抗凝血剂与糖尿病患者心房颤动患者的安全性和疗效:III期随机试验的研究水平荟萃分析
机译:非毒素K拮抗剂口腔抗凝血剂与糖尿病患者心房颤动患者的安全性和疗效:III期随机试验的研究水平荟萃分析
机译:Rivaroxaban的疗效和安全性与罗西沙巴少年患者的老年患者患者,口服,直接因子XA抑制与维生素K拮抗作用,用于预防心房颤动(Rocket AF)(130,Pg 138,2014)
机译:癌症临床试验疗效和毒性终点:比较两种非参数方法的仿真研究
机译:肝硬化患者中非维生素K拮抗剂口腔抗凝剂的出血风险:系统审查和荟萃分析
机译:直接口服抗凝剂对癌症相关血栓形成的二级预防的功效和安全性:随机对照试验和前瞻性队列研究的系统评价和荟萃分析
机译:与蓖麻血清患者在罗西沙班举行的老年人患者中与华法林患者的疗效和安全性,与维生素K拮抗,预防心房颤动中的中风和栓塞试验(Rocket AF)相比,对幼王性,口服,直接因子XA抑制相比
机译:随机临床试验的系统评价和meta分析比较受污染和脏的腹部切口的原发性与延迟性原发性皮肤闭合。